Jinwu Financial News | Most pharmaceutical stocks rose. Tongyuankang Pharmaceutical (02410) rose 18.46%, Keji Pharmaceutical (02171) rose 13.86%, Heyuan (02256) rose 11.79%, Genting Xinyao (01952) rose 10.31%, and Cansino Biotech (06185) rose 7.48%.
CMB International said that, benefiting from overseas interest rate cuts and improvements in the domestic macroeconomic environment, pharmaceuticals are expected to outperform the market as a highly flexible industry. The bank believes that macroeconomic performance is closely related to the income and expenditure of health insurance funds and health care consumption. As the policy focus shifts to stimulating the economy, the bank believes that medical equipment renewal policies are expected to be implemented at an accelerated pace, and that policies to support innovative drugs are also expected to be implemented in various regions. The CXO sector is expected to benefit from a recovery in overseas R&D demand, and the impact of the Biosafety Act may be limited. A new round of domestic health insurance negotiations is about to be implemented. Despite some pressure on the balance of health insurance funds, the bank believes that the policy trend of health insurance funding to support innovative drugs will not change.